デフォルト表紙
市場調査レポート
商品コード
1073591

皮下注生物製剤の世界市場:業界分析、市場規模、シェア、成長、動向、予測(2022年~2028年)

Global Subcutaneous Biologics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

出版日: | 発行: Value Market Research | ページ情報: 英文 160 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
皮下注生物製剤の世界市場:業界分析、市場規模、シェア、成長、動向、予測(2022年~2028年)
出版日: 2022年04月01日
発行: Value Market Research
ページ情報: 英文 160 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の皮下注生物製剤市場は、今後数年間で著しい成長が予想されています。

当レポートでは世界の皮下注生物製剤市場を調査し、市場の概要、市場の促進要因・抑制要因、業界動向、COVID-19の影響、皮下薬剤投与システム別・用途別・地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 皮下注生物製剤:業界分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
  • 潜在的バイヤーの一覧
  • マーケティングチャネル

第5章 COVID-19発生の影響分析

  • COVID-19発生の影響分析
  • COVID-19影響分析:生産・輸入・輸出・需要別
  • 市場:COVID-19以前 vs COVID-19以後
  • コロナウイルス(COVID-19)流行の推定される影響
  • COVID-19:ミクロ・マクロ要因分析

第6章 世界の皮下注生物製剤市場分析:皮下薬剤投与システム別

  • 概要:皮下薬剤投与システム別
  • 履歴・予測データ
  • 分析:皮下薬剤投与システム別
  • プレフィルドシリンジ市場:地域別
  • ウェアラブルインジェクター市場:地域別
  • 自動注射器市場:地域別
  • 薬剤調整投与システム:地域別

第7章 世界の皮下注生物製剤市場分析:用途別

  • 概要:用途別
  • 履歴・予測データ
  • 分析:用途別
  • クローン病向け市場:地域別
  • 関節リウマチ向け市場:地域別
  • 乳がん向け市場:地域別
  • 白血病向け市場:地域別
  • リンパ腫向け市場:地域別
  • 乾癬向け市場:地域別

第8章 世界の皮下注生物製剤市場分析:地域別

  • 地域別の見通し
  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 皮下注生物製剤会社の競合情勢

  • 皮下注生物製剤市場の競争状態
  • パートナーシップ/コラボレーション/契約
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Biogen Idec
  • Amgen, Inc.
  • Genentech Inc.
  • F. Hoffmann-La Roche AG
  • AbbVie, Inc.
  • Eisai, Inc.
  • Takeda Pharmaceutical Company Ltd.
  • Pfizer Ltd.
  • Bristol-Myers Squibb
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Subcutaneous Drug Delivery Systems (USD MN)
  • Prefilled Syringes Market by Geography (USD MN)
  • Wearable Injectors Market by Geography (USD MN)
  • Auto-injectors Market by Geography (USD MN)
  • Drug Reconstitution Delivery Systems. Market by Geography (USD MN)
  • Analysis Market by Applications (USD MN)
  • Crohn's Disease Market by Geography (USD MN)
  • Rheumatoid Arthritis Market by Geography (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Leukemia Market by Geography (USD MN)
  • Lymphoma Market by Geography (USD MN)
  • Psoriasis Market by Geography (USD MN)
  • Global Subcutaneous Biologics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Subcutaneous Biologics Report
  • Market Research Process
  • Market Research Methodology
  • Global Subcutaneous Biologics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Subcutaneous Drug Delivery Systems
  • Market Attractiveness Analysis by Applications
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Subcutaneous Drug Delivery Systems (USD MN)
  • Prefilled Syringes Market by Geography (USD MN)
  • Wearable Injectors Market by Geography (USD MN)
  • Auto-injectors Market by Geography (USD MN)
  • Drug Reconstitution Delivery Systems. Market by Geography (USD MN)
  • Global Market Analysis by Applications (USD MN)
  • Crohn's Disease Market by Geography (USD MN)
  • Rheumatoid Arthritis Market by Geography (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Leukemia Market by Geography (USD MN)
  • Lymphoma Market by Geography (USD MN)
  • Psoriasis Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11214386

Value Market Research deeply researched the Global Subcutaneous Biologics Market to foresee a significant growth in the industry over the upcoming years. The global subcutaneous biologics market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global subcutaneous biologics market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this subcutaneous biologics market.

The next sections of the subcutaneous biologics market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Subcutaneous Drug Delivery Systems

Prefilled Syringes

Wearable Injectors

Auto-injectors

Drug Reconstitution Delivery Systems.

By Applications

Crohn's Disease

Rheumatoid Arthritis

Breast Cancer

Leukemia

Lymphoma

Psoriasis

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SUBCUTANEOUS BIOLOGICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Subcutaneous Drug Delivery Systems
    • 3.7.2 By Applications
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL SUBCUTANEOUS BIOLOGICS MARKET ANALYSIS BY SUBCUTANEOUS DRUG DELIVERY SYSTEMS

  • 6.1 Overview by Subcutaneous Drug Delivery Systems
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Subcutaneous Drug Delivery Systems
  • 6.4 Prefilled Syringes Market by Regions
  • 6.6 Wearable Injectors Market by Regions
  • 6.5 Auto-injectors Market by Regions
  • 6.7 Drug Reconstitution Delivery Systems. Market by Regions

7 . GLOBAL SUBCUTANEOUS BIOLOGICS MARKET ANALYSIS BY APPLICATIONS

  • 7.1 Overview by Applications
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Applications
  • 7.4 Crohn's Disease Market by Regions
  • 7.5 Rheumatoid Arthritis Market by Regions
  • 7.6 Breast Cancer Market by Regions
  • 7.7 Leukemia Market by Regions
  • 7.8 Lymphoma Market by Regions
  • 7.9 Psoriasis Market by Regions

8 . GLOBAL SUBCUTANEOUS BIOLOGICS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE SUBCUTANEOUS BIOLOGICS COMPANIES

  • 9.1. Subcutaneous Biologics Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF SUBCUTANEOUS BIOLOGICS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Biogen Idec
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Amgen, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Genentech Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. F. Hoffmann-La Roche AG
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. AbbVie, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Eisai, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Takeda Pharmaceutical Company Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Pfizer Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Bristol-Myers Squibb
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies